Form 4: Perrigo EVP & CSO Boosts Stake with RSU Conversion

Perrigo Company plc's EVP and CSO, Abigail Lennox, increased her direct ownership by 1,525 ordinary shares following the conversion of Restricted Stock Units.

Summary

• Abigail Lennox, EVP and CSO of Perrigo Company plc, acquired 3,185 ordinary shares through the conversion of Restricted Stock Units (RSUs) on February 6, 2026.
• Concurrently, 1,660 ordinary shares were disposed of at $14.64 per share to cover tax obligations related to the RSU vesting.
• The net effect of these transactions is an increase of 1,525 ordinary shares in Ms. Lennox's direct beneficial ownership.
• Following these transactions, Ms. Lennox beneficially owns 2,780 ordinary shares directly and 6,368 Restricted Stock Units (derivative securities).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal. While a portion of shares were sold for tax purposes, the net increase in direct insider ownership suggests continued confidence from a key executive.

Positives

• Abigail Lennox, a key executive (EVP and CSO), increased her direct beneficial ownership of Perrigo Company plc ordinary shares by a net of 1,525 shares.
• The acquisition of shares through RSU conversion indicates the vesting of long-term incentive awards, aligning management's interests with shareholders.

Negatives

• A portion of the shares (1,660) were disposed of to cover tax liabilities, which is a common practice but reduces the total number of shares directly added to the insider's holdings.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly net acquisitions, can signal management's confidence in the company's future performance within the consumer healthcare and pharmaceutical sectors. This transaction reflects a routine vesting and tax withholding event for executive compensation.

Stakeholder Impact

• Shareholders: The net increase in executive ownership aligns management's interests with shareholders, potentially signaling confidence in future performance.
• Employees: This transaction is part of a standard executive compensation package, reflecting the company's incentive structure for its leadership.

Next Steps

• Future vesting events for the remaining 6,368 Restricted Stock Units will occur in 3 equal annual installments beginning February 6, 2026, which may lead to further share acquisitions by Ms. Lennox.

Key Dates

Recommendation

The filing details a routine insider transaction involving the vesting of Restricted Stock Units and subsequent tax withholding, resulting in a net increase in the executive's direct share ownership. While a net acquisition by an insider is generally positive, this specific transaction is part of a pre-scheduled compensation event rather than a discretionary open-market purchase. It reinforces alignment but does not present new fundamental information warranting a strong 'buy' or 'sell' recommendation. Therefore, a 'hold' recommendation is appropriate, acknowledging the positive alignment without overstating the impact of a scheduled compensation event.

Keywords

Perrigo Company plc, PRGO, Insider Trading, Form 4, Abigail Lennox, Restricted Stock Units, Equity Compensation, Executive Ownership, Pharmaceuticals, Consumer Healthcare